Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Hormonal Implants Market Share

ID: MRFR//6770-HCR | 105 Pages | Author: Kinjoll Dey| November 2024

The Hormonal Implants Market is a particular fragment inside the healthcare business, offering long-term and viable contraception and hormone replacement therapy arrangements. Accomplishing momentous areas of strength for an offer situating in this powerful area requires an essential combination of item development, administrative consistency, designated marketing, and coordinated efforts.
Organizations in the Hormonal Implants Market focus on consistent advancement in item improvement. This includes upgrading the plan, definition, and conveyance components of hormonal implants to further develop viability, term, and client fulfillment. Progressing innovative work endeavors add to remaining ahead in the vital landscape.
To take care of different patient necessities, organizations center around fostering a far-reaching arrangement of hormonal implants. Offering varieties in hormone combinations, terms, and signs empowers organizations to address the special necessities of various socioeconomics and ailments.
Shaping vital coordinated efforts with healthcare suppliers, including gynecologists and family planning centers, is essential. These joint efforts work with item supports, make channels for successful diffusion, and give important input to item improvement considering certifiable use cases.
Given the sensitive idea of hormonal implants, administrative consistency is foremost. Organizations guarantee their items fulfill worldwide administrative guidelines and go through thorough testing to ensure wellbeing and viability. Agreeing with administrative prerequisites constructs trust among healthcare experts and expected clients.
Designated marketing techniques are fundamental for market situating. Organizations put resources into instructive projects and marketing campaigns to raise awareness about the advantages of hormonal implants. These drives target healthcare experts as well as engage expected clients to settle on informed conclusions about contraception or hormone replacement therapy.
Valuing assumes a huge part in market share situating. Organizations take on adaptable estimating models, considering factors, for example, manufacture costs, market demand, and reasonableness for various segment fragments. Guaranteeing accessibility to a wide scope of clients improves market entrance.
Backing for Long-Acting and Reversible Contraception (LARC) is fundamental for market situating. Organizations effectively partake in campaigns advancing the advantages of LARC methods like hormonal implants, underscoring their adequacy and accommodation for clients looking for long-term contraception.
Organizations focus on present market reconnaissance on screen this present reality execution of hormonal implants. Gathering and coordinating client criticism considers consistent improvement in item configuration, tending to any uncertainties or secondary effects expeditiously, and maintaining a positive brand image.

Hormonal Implants Market Highlights:

Hormonal Implants Market Trends

Hormonal Implants Market Analysis

Hormonal Implants Market Share

Hormonal Implants Companies

Global Hormonal Implants Market Overview

Hormonal Implants Market Size was valued at USD 0.45 Billion in 2023. The Global Hormonal Implants industry is projected to grow from USD 0.47 Billion in 2024 to USD 0.72 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.98% during the forecast period (2024 - 2032).

Hormonal Implants Market

Hormonal implants are a highly effective and very safe form of birth control in the shape of a tiny tube that is placed under the skin of a woman’s upper arm. The size of the implant is as small as a toothpick and are made of flexible plastic, the implant contains a type of progestin hormone that stops the ovaries from releasing eggs.

Additionally, higher safety from unwanted pregnancies, suitable government programs, raising awareness of contraceptives, and the growing research & development in the market is anticipated to fuel the market growth. For instance, a study stated that no pregnancy was observed in a control group of women, using the Etonogestrel-Releasing Contraceptive Implant, for a period of 5 years.

On the other hand, related cases of side-effects, pricing variation, and limited availability of the product are hampering the growth of the market during the assessment period. Moreover, major companies in the market are involved in research & development, collaborations, and mergers to sustain their position in the market.

For instance, in May 2016, ALLERGAN took an initiative to help the US military servicewomen access LILETTA at a Federal Supply Schedule (FSS) price of USD 55.83 to military treatment facilities nationwide. The initiative also includes an educational effort to raise contraception awareness among healthcare providers treating the US military servicewomen.

Hormonal Implants Market Segmentation

The global hormonal implants market has been segmented based on the hormone, type, distribution sector, end user, and region.

The market, based on the hormone, has been bifurcated into levonorgestrel and etonogestrel. The levonorgestrel segment is expected to hold a major share in the market due to the wider preferability and longer durability. The market, based on, distribution sector has been further sub-segmented into a public sector and private sector.

The public sector is expected to hold a major share, due to increasing adoption rates of hormonal implants in public healthcare facilities under various government regulations. The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The hormonal implants market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European hormonal implants market has been sub-divided into Western Europe and Eastern Europe.

Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hormonal implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hormonal implants market in the Middle East & Africa has been divided into the Middle East and Africa.

Hormonal Implants Market Key Players

Bayer HealthCare

Shanghai Dahua Pharmaceuticals Co., Ltd

Merck & Co., Inc.

Allergan

Others

Hormonal Implants Market Regional Analysis

The market in the Americas is expected to dominate the global hormonal implants market due to the increasing per capita healthcare expenditure and the high adoption of new technology in the region.

According to government regulations, health insurance plans must cover all methods of birth control (including the implants), in the US, is expected to drive the market growth. Furthermore, increasing expenses in research by healthcare bodies is expected to fuel the growth of the market in this region.

The market in Europe showed a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system, an alternative for a surgical abortion, and the involvement of key companies. For instance, a study conducted by the European Journal of Contraception & Reproductive Health Care states that the most popular long-acting reversible contraception among European women were the levonorgestrel-releasing intrauterine system and copper intrauterine device. Therefore, the market is expected to grow during the forecast period.

The market in Asia-Pacific is projected to have a steady growth rate during the forecast period owing to the increasing awareness for contraceptives and increasing government initiatives for healthcare reforms. The market in the Middle East & Africa is projected to account for the least share of the global market due to low per capita disposable incomes in the region.

Global Hormonal Implants Market, by Hormone

Levonorgestrel

Etonogestrel

Global Hormonal Implants Market, by Type

One Rod Device

Two Rod Device

Global Hormonal Implants Market, by Distribution Sector

Public Sector

Private Sector

Global Hormonal Implants Market, By End User

Hospitals & Clinics

Academic & Research Institutes

Global Hormonal Implants Market, by Region

Americas
- North America
  - US
  - Canada
- Latin America

Europe
- Western Europe
  - Germany
  - France
  - Italy
  - Spain
  - UK
  - Rest of Western Europe
- Eastern Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

Middle East & Africa
- Middle East
- Africa

Intended Audience

Research and development (R&D) companies

Medical device companies

Government research institutes

Academic institutes and universities

Market research and consulting

Hormonal Implants Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions